| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773845 | Kidney International Reports | 2018 | 9 Pages |
Abstract
Anti-EPOR antibodies might be involved in the progression of renal lesions and in the impaired erythropoiesis in type 2 diabetic patients with CKD. Furthermore, the presence of anti-EPOR antibodies may be an additional predictor for end-stage renal disease in type 2 diabetes.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Akinori Hara, Kengo Furuichi, Akihiko Koshino, Haruka Yasuda, Trang Thi Thu Tran, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Shuichi Kaneko, Hiroyuki Nakamura, Takashi Wada,